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Cholangiopathy is pathologically and pathogenetically het-
erogeneous and presents a broad spectrum of clinical man-
ifestations. A majority of them are known for many years,
while some are newly emerging diseases. Recent advances
in biology and medicine have introduced new technologies
to study the cholangiocyte biologies and physiologies and
the genetics, and the pathogenesis and pathology of cholan-
giopathy is now being evaluated from the aspects of experi-
mental and clinical studies. Several animal models have been
developed for autoimmune and genetic cholangiopathy such
as primary biliary cirrhosis and polycystic disease of the liver
andbiliarytract.Knowledgeandunderstandingofthesecon-
ditions have led to the development of promising therapies
and novel tools to characterize these clinical conditions.
In this special issue of cholangiopathy, several important
aspects of cholangiophany are addressed with respect to
recent progress. First, in the tutorial review, the anatomy
and physiology of the biliary tree and physiologic func-
tions of biliary epithelial cells are brieﬂy introduced for
better understanding of cholangiopathy. Several important
and basic mechanisms and clinicopathological features of
cholangiopathy are also described. Then, Drs. M. Harada
and Y. Nokanuma describe the immunological aspects of
biliary tree itself and also cholangiopathy with respect to
innate immunity. Several biliary diseases, particularly biliary
atresia, are now being discussed from the aspect of innate
immunity. Then, Dr. Zen et al. introduce a newly emerging
disease of IgG4-related disease with respect to biliary tract.
Many clinicians and pathologists try to categorize this
disease family showing a well response to steroid therapy
and involving several organs. Dr. Shimoda et al. and Dr.
Sasaki et al. focused on the pathogenesis of primary biliary
cirrhosis from aspects of fractalkine and cellular senescence,
respectively. Dr. Shimoda et al. stress the importance, of
innate and acquired immunity and Drs. K. Sasaki and Y.
Nakanuma notice the participation of autophagy in the
inductionofcellularsenescenceofbiliaryepithelialcells.Drs.
K. Tsuneyama et al. discuss the animal models of primary
biliary cirrhosis which are available. Dr. Ninomiya et al.
introduced a new animal model of primary biliary cirrhosis.
These models will contribute to the understanding of the
pathogenesis of primary biliary cirrhosis in near future. Dr.
Y. Sato et al. report their accumulating data on unique
animal model of Caroli’s disease and discuss its molecular
mechanism. This animal model resembles the autosomal-
recessive polycystic disease of the kidney and liver. Lastly,
Drs. G. Fava and I. Lorenzini discuss molecular pathogenesis
of cholangiocarcinoma, another topic of neoplastic cholan-
giopathy. New biomarker and molecular targeting therapies
are now rapidly evolving in this ﬁeld. We are sure that
this special issue will contribute to the further progress of
understanding and treatment of cholangiopathy.
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